ATLANTA, April 15, 2013 /PRNewswire-USNewswire/ -- The Arthritis Foundation announces the appointment of John Vernachio , Ph.D. as vice president of research effective April 15. In his new role he will provide leadership and direction to further the Arthritis Foundation research program and the organization's commitment to finding a cure and better, safer treatments for the nation's leading cause of disability. Vernachio will succeed Dr. John Hardin , who will assume a new role within the organization developing and implementing flagship initiatives in osteoarthritis.
" John Vernachio is a world-class scientist and director in biotechnology with a proven track record," says Arthritis Foundation Chief Mission Officer, Jennifer Griffiths , Ph.D. "I am confident that under his leadership the Arthritis Foundation will continue its legacy in driving targeted research initiatives that will push us toward a cure."
Vernachio brings to the Arthritis Foundation extensive research leadership and expertise, serving as a researcher and technical director in the biotechnology sector for more than 20 years. Most recently, he served as vice president of biology for Inhibitex, Inc. Earlier, he held supervisory and leadership roles in several biotechnology companies including Baxter Healthcare and Valentis, Inc. In addition, he is an author on over 20 peer-reviewed scientific articles, numerous scientific presentations and is a co-inventor on 10 patent applications.
A graduate of the University of Vermont, Vernachio earned a Bachelor of Science degree in Animal Science in 1984. He received a doctorate in bioche
|SOURCE Arthritis Foundation|
Copyright©2012 PR Newswire.
All rights reserved